This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BBK Worldwide Expands Mobile Strategy For Patient Recruitment To Include "In-App" Advertising

BBK is making mobile products and services – and their integration into recruitment initiatives – more attainable for sponsors. The company advocates a strategy-driven multichannel approach. "To remain competitive in today's marketplace, going mobile is no longer a question but a strategic imperative," comments Stumm. "Companies lacking a mobile-friendly website drive approximately 61 percent of their mobile traffic to competitors. This is an alarming statistic. If you are weighing the costs to develop a mobile arm to your patient recruitment campaign, it's important to weigh the risks associated with not having one as well."

BBK's suite of mobile recruitment and retention products and services are available for purchase at www.Shop.BBKWorldwide.com.

About BBK Worldwide (bbkworldwide.com)Founded in 1983, BBK Worldwide is the recognized global leader in patient recruitment. The company is renowned for accelerating time to market for new and improved medicines and treatments. Through its partner companies, TCN Technologies and Agency 320, BBK offers the industry the most sophisticated technology, creative, and media services. BBK meets accreditation standards of the Women's Business Enterprise National Council and is certified as a Safe Harbor company.

SOURCE BBK Worldwide

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs